Form 8-K - Current report:
SEC Accession No. 0001104659-26-023534
Filing Date
2026-03-04
Accepted
2026-03-04 16:59:47
Documents
17
Period of Report
2026-03-04
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm266774d4_8k.htm   iXBRL 8-K 55538
2 EXHIBIT 4.2 tm267894d1_ex4-2.htm EX-4.2 450993
3 EXHIBIT 5.1 tm267894d1_ex5-1.htm EX-5.1 16137
8 GRAPHIC tm267894d1_ex4-2img01.jpg GRAPHIC 4092
9 GRAPHIC tm267894d1_ex5-1img001.jpg GRAPHIC 7792
  Complete submission text file 0001104659-26-023534.txt   885654

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA abbv-20260304.xsd EX-101.SCH 4500
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE abbv-20260304_def.xml EX-101.DEF 30264
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE abbv-20260304_lab.xml EX-101.LAB 40517
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE abbv-20260304_pre.xml EX-101.PRE 28468
20 EXTRACTED XBRL INSTANCE DOCUMENT tm266774d4_8k_htm.xml XML 11280
Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 (847) 932-7900
AbbVie Inc. (Filer) CIK: 0001551152 (see all company filings)

EIN.: 320375147 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35565 | Film No.: 26722471
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)